Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' RUBERG M' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 49 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lambeng, N; Michel, PP; Agid, Y; Ruberg, M
      The relationship between differentiation and survival in PC12 cells treated with cyclic adenosine monophosphate in the presence of epidermal growth factor or nerve growth factor

      NEUROSCIENCE LETTERS
    2. Hartmann, A; Troadec, JD; Hunot, S; Kikly, K; Faucheux, BA; Mouatt-Prigent, A; Ruberg, M; Agid, Y; Hirsch, EC
      Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis

      JOURNAL OF NEUROSCIENCE
    3. Troadec, JD; Marien, M; Darios, F; Hartmann, A; Ruberg, M; Colpaert, F; Michel, PP
      Noradrenaline provides long-term protection to dopaminergic neurons by reducing oxidative stress

      JOURNAL OF NEUROCHEMISTRY
    4. Douhou, A; Troadec, JD; Ruberg, M; Raisman-Vozari, R; Michel, PP
      Survival promotion of mesencephalic dopaminergic neurons by depolarizing concentrations of K+ requires concurrent inactivation of NMDA or AMPA/kainate receptors

      JOURNAL OF NEUROCHEMISTRY
    5. Hartmann, A; Michel, PP; Troadec, JD; Mouatt-Prigent, A; Faucheux, BA; Ruberg, M; Agid, Y; Hirsch, EC
      Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neuronsin Parkinson's disease?

      JOURNAL OF NEUROCHEMISTRY
    6. Vila, M; Perier, C; Feger, J; Yelnik, J; Faucheux, B; Ruberg, M; Raisman-Vozari, R; Agid, Y; Hirsch, EC
      Evolution of changes in neuronal activity in the subthalamic nucleus of rats with unilateral lesion of the substantia nigra assessed by metabolic andelectrophysiological measurements

      EUROPEAN JOURNAL OF NEUROSCIENCE
    7. Murer, MG; Dziewczapolski, G; Salin, P; Vila, M; Tseng, KY; Ruberg, M; Rubinstein, M; Kelly, MA; Grandy, DK; Low, MJ; Hirsch, E; Raisman-Vozari, R; Gershanik, O
      The indirect basal ganglia pathway in dopamine D-2 receptor-deficient mice

      NEUROSCIENCE
    8. Orieux, G; Francois, C; Feger, J; Yelnik, J; Vila, M; Ruberg, M; Agid, Y; Hirsch, EC
      Metabolic activity of excitatory parafascicular and pedunculopontine inputs to the subthalamic nucleus in a rat model of Parkinson's disease

      NEUROSCIENCE
    9. Hartmann, A; Hunot, S; Michel, PP; Muriel, MP; Vyas, S; Faucheux, BA; Mouatt-Prigent, A; Turmel, H; Srinivasan, A; Ruberg, M; Evan, GI; Agid, Y; Hirsch, EC
      Caspase-3: A vulnerability factor and final effector in apoptotic death ofdopaminergic neurons in Parkinson's disease

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    10. Muriel, MP; Lambeng, N; Darios, F; Michel, PP; Hirsch, EC; Agid, Y; Ruberg, M
      Mitochondrial free calcium levels (Rhod-2 fluorescence) and ultrastructural alterations in neuronally differentiated PC12 cells during ceramide-dependent cell death

      JOURNAL OF COMPARATIVE NEUROLOGY
    11. Cancel, G; Duyckaerts, C; Holmberg, M; Zander, C; Yvert, G; Lebre, AS; Ruberg, M; Faucheux, B; Agid, Y; Hirsch, E; Brice, A
      Distribution of ataxin-7 in normal human brain and retina

      BRAIN
    12. Lopes, J; Tardieu, S; Silander, K; Blair, I; Vandenberghe, A; Palau, F; Ruberg, M; Brice, A; LeGuern, E
      Homologous DNA exchanges in humans can be explained by the yeast double-strand break repair model: a study of 17p11.2 rearrangements associated with CMT1A and HNPP

      HUMAN MOLECULAR GENETICS
    13. Murer, MG; Raisman-Vozari, R; Yan, Q; Ruberg, M; Agid, Y; Michel, PP
      Survival factors promote BDNF protein expression in mesencephalic dopaminergic neurons

      NEUROREPORT
    14. Michel, PP; Lambeng, N; Ruberg, M
      Neuropharmacologic aspects of apoptosis: Significance for neurodegenerative diseases

      CLINICAL NEUROPHARMACOLOGY
    15. Vila, M; Marin, C; Ruberg, M; Jimenez, A; Raisman-Vozari, R; Agid, Y; Tolosa, E; Hirsch, EC
      Systemic administration of NMDA and AMPA receptor antagonists reverses theneurochemical changes induced by nigrostriatal denervation in basal ganglia

      JOURNAL OF NEUROCHEMISTRY
    16. Michel, PP; Marien, M; Ruberg, M; Colpaert, F; Agid, Y
      Adenosine prevents the death of mesencephalic dopaminergic neurons by a mechanism that involves astrocytes

      JOURNAL OF NEUROCHEMISTRY
    17. Lambeng, N; Michel, PP; Brugg, B; Agid, Y; Ruberg, M
      Mechanisms of apoptosis in PC12 cells irreversibly differentiated with nerve growth factor and cyclic AMP

      BRAIN RESEARCH
    18. LOPES J; RAVISE N; VANDENEBRGHE A; PALAU F; IONASESCU V; MAYER M; LEVY N; WOOD N; TACHI N; BOUCHE P; LATOUR P; RUBERG M; BRICE A; LEGUERN E
      SEX-DEPENDENT REARRANGEMENTS RESULTING IN CMT1A AND HNPP

      European journal of human genetics
    19. STEVANIN G; GIUNTI P; DAVID G; BELAL S; DURR A; RUBERG M; WOOD N; BRICE A
      DE-NOVO EXPANSION OF INTERMEDIATE ALLELES IN SPINOCEREBELLAR ATAXIA-7

      Human molecular genetics (Print)
    20. LOPES J; RAVISE N; VANDENBERGHE A; PALAU F; IONASESCU V; MAYER M; LEVY N; WOOD N; TACHI N; BOUCHE P; LATOUR P; RUBERG M; BRICE A; LEGUERN E
      FINE MAPPING OF DE-NOVO CMT1A AND HNPP REARRANGEMENTS WITHIN CMT1A-REPS EVIDENCES 2 DISTINCT SEX-DEPENDENT MECHANISMS AND CANDIDATE SEQUENCES INVOLVED IN RECOMBINATION

      Human molecular genetics
    21. DAVID G; ABBAS N; STEVANIN G; DURR A; YVERT G; CANCEL G; WEBER C; IMBERT G; SAUDOU F; ANTONIOU E; DRABKIN H; GEMMILL R; GIUNTI P; BENOMAR A; WOOD N; RUBERG M; AGID Y; MANDEL JL; BRICE A
      CLONING OF THE SCA7 GENE REVEALS A HIGHLY UNSTABLE CAG REPEAT EXPANSION

      Nature genetics
    22. LEVY R; HAZRATI LN; HERRERO MT; VILA M; HASSANI OK; MOUROUX M; RUBERG M; ASENSI H; AGID Y; FEGER J; OBESO JA; PARENT A; HIRSCH EC
      REEVALUATION OF THE FUNCTIONAL-ANATOMY OF THE BASAL GANGLIA IN NORMALAND PARKINSONIAN STATES

      Neuroscience
    23. VILA M; LEVY R; HERRERO MT; RUBERG M; FAUCHEUX B; OBESO JA; AGID Y; HIRSCH EC
      CONSEQUENCES OF NIGROSTRIATAL DENERVATION ON THE FUNCTIONING OF THE BASAL GANGLIA IN HUMAN AND NONHUMAN-PRIMATES - AN IN-SITU HYBRIDIZATIONSTUDY OF CYTOCHROME-OXIDASE SUBUNIT-I MESSENGER-RNA

      The Journal of neuroscience
    24. ANGLADE P; VYAS S; JAVOYAGID F; HERRERO MT; MICHEL PP; MARQUEZ J; MOUATTPRIGENT A; RUBERG M; HIRSCH EC; AGID Y
      APOPTOSIS AND AUTOPHAGY IN NIGRAL NEURONS OF PATIENTS WITH PARKINSONS-DISEASE

      Histology and histopathology
    25. RUBERG M; FRANCELANORD V; BRUGG B; LAMBENG N; MICHEL PP; ANGLADE P; HUNOT S; DAMIER P; FAUCHEUX B; HIRSCH E; AGID Y
      NEURONAL DEATH DUE TO APOPTOSIS IN PARKINSONS-DISEASE

      Revue neurologique
    26. HUNOT S; BRUGG B; RICARD D; MICHEL PP; MURIEL MP; RUBERG M; FAUCHEUX BA; AGID Y; HIRSCH EC
      NUCLEAR TRANSLOCATION OF NF-KAPPA-B IS INCREASED IN DOPAMINERGIC-NEURONS OF PATIENTS WITH PARKINSON-DISEASE

      Proceedings of the National Academy of Sciences of the United Statesof America
    27. MICHEL PP; RUBERG M; AGID Y
      RESCUE OF MESENCEPHALIC DOPAMINE NEURONS BY ANTICANCER DRUG CYTOSINE-ARABINOSIDE

      Journal of neurochemistry
    28. FRANCELANORD V; BRUGG B; MICHEL PP; AGID Y; RUBERG M
      MITOCHONDRIAL FREE-RADICAL SIGNAL IN CERAMIDE-DEPENDENT APOPTOSIS - APUTATIVE MECHANISM FOR NEURONAL DEATH IN PARKINSONS-DISEASE

      Journal of neurochemistry
    29. RUBERG M; FRANCELANORD V; LAMBENG N; NGUYEN TT; CERQUEIRA E; BRUGG B; MICHEL PP; HUNOT S; FAUCHEUX B; HIRSCH E; AGID Y
      HYPOTHETICAL MECHANISMS OF NEURODEGENERATION IN PARKINSONS-DISEASE

      Journal of neurochemistry
    30. RUBERG M; BRUGG B; PRIGENT A; HIRSCH E; BRICE A; AGID Y
      IS DIFFERENTIAL REGULATION OF MITOCHONDRIAL TRANSCRIPTS IN PARKINSONS-DISEASE RELATED TO APOPTOSIS

      Journal of neurochemistry
    31. BOISSIERE F; FAUCHEUX B; RUBERG M; AGID Y; HIRSCH EC
      DECREASED TRKA GENE-EXPRESSION IN CHOLINERGIC NEURONS OF THE STRIATUMAND BASAL FOREBRAIN OF PATIENTS WITH ALZHEIMERS-DISEASE

      Experimental neurology
    32. AGID Y; HIRSCH E; ANGLADE P; MICHEL P; BRUGG B; RUBERG M
      AGING, DISEASE AND DEATH OF NERVE-CELLS

      Acta neurologica belgica
    33. DEVILLEMEUR TB; DESLYS JP; PRADEL A; SOUBRIE C; ALPEROVITCH A; TARDIEU M; CHAUSSAIN JL; HAUW JJ; DORMONT D; RUBERG M; AGID Y
      CREUTZFELDT-JAKOB-DISEASE FROM CONTAMINATED GROWTH-HORMONE EXTRACTS IN FRANCE

      Neurology
    34. HERRERO MT; LEVY R; RUBERG M; LUQUIN MR; VILLARES J; GUILLEN J; FAUCHEUX B; JAVOYAGID F; GURIDI J; AGID Y; OBESO JA; HIRSCH EC
      CONSEQUENCE OF NIGROSTRIATAL DENERVATION AND L-DOPA THERAPY ON THE EXPRESSION OF GLUTAMIC-ACID DECARBOXYLASE MESSENGER-RNA IN THE PALLIDUM

      Neurology
    35. VILA M; HERRERO MT; LEVY R; FAUCHEUX B; RUBERG M; GUILLEN J; LUQUIN MR; GURIDI J; JAVOYAGID F; AGID Y; OBESO JA; HIRSCH EC
      CONSEQUENCES OF NIGROSTRIATAL DENERVATION ON THE GAMMA-AMINOBUTYRIC ACIDIC NEURONS OF SUBSTANTIA-NIGRA PARS RETICULATA AND SUPERIOR COLLICULUS IN PARKINSONIAN SYNDROMES

      Neurology
    36. BRUGG B; AGID Y; RUBERG M
      TRANSFORMING GROWTH-FACTOR-ALPHA CERAMIDE-DEPENDENT SIGNAL-TRANSDUCTION, AND THE DEATH OF DOPAMINERGIC-NEURONS IN PARKINSONS-DISEASE

      Neurology
    37. ANGLADE P; VYAS S; JAVOYAGID F; HERRERO MT; MICHEL PP; MARQUEZ J; MOUATTPRIGENT A; RUBERG M; HIRSCH EC; AGID Y
      APOPTOTIC DEGENERATION OF NIGRAL DOPAMINERGIC-NEURONS IN PARKINSONS-DISEASE

      Neurology
    38. BRUGG B; MICHEL PP; AGID Y; RUBERG M
      CERAMIDE INDUCES APOPTOSIS IN CULTURED MESENCEPHALIC NEURONS

      Journal of neurochemistry
    39. LAMBENG N; FRANCELANORD V; BRUGG B; ANGLADE P; MICHEL PP; AGID Y; RUBERG M
      CHARACTERIZATION OF A SIGNALING PATHWAY UNDERLYING NEURONAL CELL-DEATH AFTER TROPHIC SUPPORT WITHDRAWAL OR TNF-ALPHA TREATMENT

      Journal of neurochemistry
    40. GURIDI J; HERRERO MT; LUQUIN MR; GUILLEN J; RUBERG M; LAGUNA J; VILA M; JAVOYAGID F; AGID Y; HIRSCH E; OBESO JA
      SUBTHALAMOTOMY IN PARKINSONIAN MONKEYS - BEHAVIORAL AND BIOCHEMICAL-ANALYSIS

      Brain
    41. LEVY R; HERRERO MT; RUBERG M; VILLARES J; FAUCHEUX B; GURIDI J; GUILLEN J; LUQUIN MR; JAVOYAGID F; OBESO JA; AGID Y; HIRSCH EC
      EFFECTS OF NIGROSTRIATAL DENERVATION AND L-DOPA THERAPY ON THE GABAERGIC NEURONS OF THE STRIATUM IN MPTP-TREATED MONKEYS AND PARKINSONS-DISEASE - AN IN-SITU HYBRIDIZATION STUDY OF GAD(67) MESSENGER-RNA

      European journal of neuroscience
    42. LEVY R; RUBERG M; HERRERO MT; VILLARES J; JAVOYAGID F; AGID Y; HIRSCH EC
      ALTERATIONS OF GABAERGIC NEURONS IN THE BASAL GANGLIA OF PATIENTS WITH SUPRANUCLEAR PALSY - AN IN-SITU HYBRIDIZATION STUDY OF GAD67 MESSENGER-RNA

      Neurology
    43. RUBERG M; SCHERMAN D; JAVOYAGID F; AGID Y
      DOPAMINE DENERVATION, AGE-OF-ONSET, AND PARKINSONS-DISEASE

      Neurology
    44. LEVY R; RUBERG M; HERRERO MT; VILLARES J; JAVOYAGID F; AGID Y; HIRSCH EC
      ALTERATIONS OF GABAERGIC NEURONS IN THE BASAL GANGLIA OF PATIENTS WITH PROGRESSIVE SUPRANUCLEAR PALSY - AN IN-SITU HYBRIDIZATION STUDY OF GAD(67) MESSENGER-RNA

      Neurology
    45. MICHEL PP; VYAS S; ANGLADE P; RUBERG M; AGID Y
      MORPHOLOGICAL AND MOLECULAR CHARACTERIZATION OF THE RESPONSE OF DIFFERENTIATED PC12 CELLS TO CALCIUM STRESS

      European journal of neuroscience
    46. PHAMDINH D; ALLINQUANT B; RUBERG M; DELLAGASPERA B; NUSSBAUM JL; DAUTIGNY A
      CHARACTERIZATION AND EXPRESSION OF THE CDNA CODING FOR THE HUMAN MYELIN OLIGODENDROCYTE GLYCOPROTEIN/

      Journal of neurochemistry
    47. STEVANIN G; LEGUERN E; RAVISE N; CHNEIWEISS H; DURR A; CANCEL G; VIGNAL A; BOCH AL; RUBERG M; PENET C; POTHIN Y; LAGROUA I; HAGUENAU M; RANCUREL G; WEISSENBACH J; AGID Y; BRICE A
      A 3RD LOCUS FOR AUTOSOMAL-DOMINANT CEREBELLAR-ATAXIA TYPE-I MAPS TO CHROMOSOME 14Q24.3-QTER - EVIDENCE FOR THE EXISTENCE OF A 4TH LOCUS

      American journal of human genetics
    48. HERRERO MT; HIRSCH EC; KASTNER A; RUBERG M; LUQUIN MR; LAGUNA J; JAVOYAGID F; OBESO JA; AGID Y
      DOES NEUROMELANIN CONTRIBUTE TO THE VULNERABILITY OF CATECHOLAMINERGIC NEURONS IN MONKEYS INTOXICATED WITH MPTP

      Neuroscience
    49. HERRERO MT; RUBERG M; HIRSCH EC; MOUATT A; TOBIN AJ; AGID Y; OBESO JA; JAVOYAGID F
      IN-SITU HYBRIDIZATION OF GAD MESSENGER-RNA IN MONKEY AND HUMAN BRAIN - QUANTIFICATION AT BOTH REGIONAL AND CELLULAR-LEVELS

      Neuroscience letters


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/08/20 alle ore 15:36:40